Acute sirolimus overdose: a multicenter case series

PLoS One. 2015 May 28;10(5):e0128033. doi: 10.1371/journal.pone.0128033. eCollection 2015.

Abstract

Background: There are few data relating to sirolimus overdose in the medical literature. Our objectives were to describe all cases of overdose with sirolimus reported to Swiss, German and Austrian Poisons Centres between 2002-2013.

Methods: An observational case-series analysis was performed to determine circumstances, magnitude, management and outcome of sirolimus overdose.

Results: Five cases of acute sirolimus overdose were reported--three in young children and two in adults. Four were accidental and one was with suicidal intent. Two patients developed symptoms probably related to sirolimus overdose: mild elevation of alkaline phosphatase, fever and gastroenteritis in a 2.5-year-old male who ingested 3 mg, and mild changes in total cholesterol in an 18-year-old female after ingestion of 103 mg. None of these events were life-threatening. Serial blood concentration measurements were performed starting 24 h after ingestion of 103 mg in a single case, and these followed a similar pharmacokinetic time-course to measurements taken after dosing in the therapeutic range.

Conclusions: Acute sirolimus overdose occurred accidentally in the majority of cases. Even large overdoses appeared to be well-tolerated, however children might be at greater risk of developing complications. Further study of sirolimus overdose is needed.

Publication types

  • Case Reports
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alkaline Phosphatase / blood
  • Child, Preschool
  • Cholesterol / blood
  • Drug Overdose / blood
  • Drug Overdose / diagnosis*
  • Drug Overdose / physiopathology
  • Female
  • Fever / blood
  • Fever / chemically induced
  • Fever / diagnosis*
  • Fever / physiopathology
  • Gastroenteritis / blood
  • Gastroenteritis / chemically induced
  • Gastroenteritis / diagnosis*
  • Gastroenteritis / physiopathology
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sirolimus / adverse effects*
  • Suicide, Attempted / prevention & control*

Substances

  • Cholesterol
  • Alkaline Phosphatase
  • Sirolimus

Grants and funding

Funding was through internal funds of the University and University Hospital Basel, the Swiss Toxicological Information Centre, and the Society of Clinical Toxicology (GfKT). SK is supported by grants from the Swiss National Science Foundation (SNF31003A-132992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.